CD8A and Miyoshi myopathy: Moreover, LAG3/GAL-3 blockade can efficiently enhance the proliferation of T cells in MM patients and functional activities of MM-specific CTL, including XBP1/CD138/CS1-targeting memory CD8+ T cells, against MM.